COVID-19: research / briefings / evidence (links)

First published: 22/05/2020 | Last updated: August 7th, 2020

For a thorough summary of addiction-related COVID-19 studies, see the Addiction Journal Bibliography. This provides a downloadable document listing articles found in PubMed involving addiction-related topics and COVID-19. It is updated weekly and all publications prior to January 2020 are removed.

 

Research / Briefings / Evidence A-Z

Addiction Journal Bibliography on COVID-19 and addiction: click here

Alcohol and Alcoholism, Alcohol and COVID-19 editorial

Alcohol & Drug Foundation, Australia -‘ Changing your drinking habits’ find out about the six signs that home isolation could be impacting your drinking: click here

ADFAM: Families in Lockdown: The effects of the COVID-19 lockdown on the family and friends of someone with an alcohol, drug or gambling problem survey report

ASH Scotland Covid-19 and smoking research –a list of published articles on scientific research which includes information or data on smoking, nicotine and Covid-19.

Australian National University report ‘Alcohol consumption during the COVID-19 period’ shows Australians are drinking alcohol more frequently during the COVID-19 pandemic than before

British Columbia Centre on Substance Use (Canada) COVID-19 resources: click here

BMJ Global Health: YouTube as a source of information on COVID-19: a pandemic of misinformation?

BMJ Tobacco Control: COVID-19 and smoking: resources, research and news: click here

BMJ Tobacco Control: resources, research and news about COVID-19 and smoking, vaping and other tobacco products: click here

BJGP Open is rapidly publishing research and editorials on COVID-19, and will be collecting all articles here 

Bristol Drug Project: Researching During A Pandemic -working with the Universities of Bristol and Bath to find out how the Coronavirus pandemic has affected the lives of people who inject drugs in Bristol.

Canadian Centre on Drug Use and Addiction: Impacts of the COVID-19 Pandemic on People Who Use Substances: What we have heard

Canadian Centre on Drug Use and Addiction (CCSA – in French & English): open versus closed: the risks associated with retail liquor stores during COVID-19click here

Canadian Centre on Drug Use and Addiction (CCSA) report: COVID-19 and cannabis smoking and vaping: four things you should know: click here

Canadian Centre on Drug Use and Addiction (CCSA): changes related to COVID-19 in the illegal drug supply and access to services, and resulting health harms (CCENDU Alert)

Canadian Centre on Substance Use and Addiction (CCSA): Boredom and Stress Drives Increased Alcohol Consumption during COVID-19: NANOS Poll Summary Report

Cochrane Clinical Answers related to COVID-19 including CCAs (free) on effective options for quitting smoking during the pandemic: click here

Drug and Alcohol Research Connections – May 2020 – latest news from NDARC, NDRI and NCETA, with a special COVID-19 focus in this issue

Drugs and Me –Preliminary Survey Results how has drug use changed during the pandemic

EMCDDA special report: COVID-19 and drugs – drug supply via darknet markets: click here

EMCDDA COVID-19: New study highlights decline in stimulant drug use but some rises in the use of cannabis, alcohol and prescription medicines to combat anxiety and depression

EMCDDA Trendspotter briefing: impact of COVID-19 on patterns of drug use and drug-related harms in Europe

Fare Australia: family violence and alcohol during COVID-19

Foundation for Alcohol Research and Education (FARE) survey shows that 20% of Australians purchased more alcohol and 70% of them are drinking more alcohol than normal, with one third now using alcohol daily during the COVID-19 pandemic: click here

Gambling Commission : Gambling business data updated during COVID-19

Health Research Board Library newsletter containing Irish and international resources on COVID-19: click here

House of Commons Nitrous Oxide: Coronavirus Parliamentary Question asking the Secretary of State for the Home Department what assessment has been made of the change in the level of the use of nitrous oxide during the covid-19 outbreak.

Imperial College London: a report on the global impact of COVID-19: click here

INPUD COVID-19 Survey Report 1: Health & Rights of People who Use Drugs in a COVID-19 Environment

International Journal of Drug Policy – Why we should all be more careful in drawing conclusions about how COVID-19 is changing drug markets

Institute of Alcohol Studies Alcohol consumption during the COVID19 lockdown: summary of emerging evidence from the UK

Irish Journal Psychological Medicine: Addiction Psychiatry and COVID-19 – Impact on patients and service provision

JAMA Psychiatry Telehealth for Substance-Using Populations in the Age of Coronavirus Disease 2019 Recommendations to Enhance AdoptionViewpoint

Journal of Public Health -Threatening increase in alcohol consumption in physicians quarantined due to coronavirus outbreak in Poland: the ALCOVID survey

London School of Economics: Illicit Drugs during Covid-19 -how has COVID-19 affected some of the most vulnerable people in society? | LSE Research

London School of Economics: Ireland’s innovative approach to supporting homeless and drug using populations during COVID-19 saved lives

National Association for Children of Alcoholics report: ‘Covid So Far, Lockdown and the Lost Children’ reports rise in calls from children whose parents have started to drink again in lockdown

National Drug and Alcohol Research Centre, UNSW Australia, research response to COVID-19: click here

National Drug and Alcohol Research Centre: Impacts of COVID-19 and associated restrictions on people who use illicit stimulants in Australia: Preliminary findings from the Ecstasy and Related Drugs Reporting System 2020

National Drug and Alcohol Research Centre Key findings from the ‘Australians’ Drug Use: Adapting to Pandemic Threats’ (ADAPT) Study

National Drug and Alcohol Research Centre: Have COVID-19 restrictions affected needle and syringe program transactions in Tasmania

Observatoire Français des Drogues et des Toxicomanies English summary of the 2nd OFDT-TREND bulletin examining changes caused by the COVID-19 pandemic and the lockdown measures in France to practices of drug users, drug services and drug trafficking

Pharmaceuticals Journal: Substance use disorder in the COVID-19 pandemic Systematic review of vulnerabilities and complications

Public Health England (PHE): emerging evidence from China shows smokers with COVID-19 are 14 times more likely to develop severe respiratory disease: click here

PHE: Wider Impacts of COVID-19 on Health (WICH) monitoring tool: PHE health intelligence teams are scoping metrics that will enable the monitoring of the indirect health impacts of COVID-19. Includes alcohol consumption and smoking

Qeios: ‘Smoking, vaping and hospitalization for COVID-19’: click here

Qeios: The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review (version 6)

Release: Impact of Coronavirus on Drug Purchases Survey

Russell Webster: Impact of coronavirus on drug use across Europe summary of the European Monitoring Centre for Drugs and Drug Addiction trendspotter study on the impact of Covid-19 on drug consumption patterns and drug-related harms

The Conversation Australia : Pot, pills and the pandemic: how coronavirus is changing the way we use drugs

The Global Drug Survey (GDS) Special Edition  report on COVID-19 highlights preliminary findings halfway through data collection. A complete report based on all data collected until June 20, 2020 follows in July | GDS, UK

The Lancet has created a COVID-19 resource centre. This resource brings together content from across The Lancet journals as it is published and is free to access: click here

The Lancet Gastroenterology & Hepatology -Effect of COVID-19 lockdown on alcohol consumption in patients with pre-existing alcohol use disorder

The Lancet Psychiatry: public health messaging and harm reduction in the time of COVID-19: click here

The Lancet Psychiatry: innovative strategies to support physical distancing among individuals with active addiction

The Lancet Respiratory Medicine: Tobacco smoking and COVID-19 infection

Toxicology Reports: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system. Editorial

UK parliament: call for experts from the Knowledge Exchange Unit: click here

UK Research and Innovation (UKRI): COVID-19, the science explained. This website will be regularly updated with the latest science information behind the COVID-19 outbreak: click here

UNODC Research Brief: COVID-19 and the drug supply chain: from production and trafficking to use

UNODC Research Brief COVID-19-related Trafficking of Medical Products as a Threat to Public Health

University College London study into the psychological and social effects of COVID-19: click here

University of Oxford researchers studying the effect of smoking, nicotine and vaping on COVID-19 severity inking primary and clinical data for the assessment of associations between smoking status and the severity of coronavirus disease

World Health Organisation (WHO) COVID-19 database – the latest scientific findings and knowledge on COVID-19. The global literature cited in the database is updated daily: click here

WHO and EMRO Q&A on tobacco, waterpipe and e-cigarette use in the context of COVID-19 (English and Arabic): click here

WHO Scientific Brief Smoking and COVID-19 click here

The SSA does not endorse nor guarantee the accuracy of the information in external sources or links, and accepts no responsibility or liability for any consequences arising from the use of such information

Every effort is made to maintain the accuracy of the information on the SSA website. However, things change all the time. If you discover any out-of-date links or if you know of other links that could be included, please let us know.